Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1975 28
1976 45
1977 56
1978 36
1979 61
1980 60
1981 50
1982 58
1983 75
1984 60
1985 37
1986 49
1987 39
1988 37
1989 24
1990 23
1991 28
1992 38
1993 59
1994 56
1995 52
1996 57
1997 55
1998 49
1999 89
2000 86
2001 122
2002 128
2003 143
2004 132
2005 129
2006 125
2007 164
2008 147
2009 155
2010 173
2011 204
2012 179
2013 165
2014 169
2015 166
2016 133
2017 118
2018 121
2019 107
2020 97
2021 84
2022 41
2023 19
2024 51

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,916 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens.
Duque-Afonso J, Rassner P, Walther K, Ihorst G, Wehr C, Marks R, Wäsch R, Bertz H, Köhler T, Frye BC, Stolz D, Zeiser R, Finke J, Maas-Bauer K. Duque-Afonso J, et al. Bone Marrow Transplant. 2024 Dec;59(12):1744-1753. doi: 10.1038/s41409-024-02422-z. Epub 2024 Sep 27. Bone Marrow Transplant. 2024. PMID: 39333758
The impact of age and renal function on the pharmacokinetics and protein binding characteristics of fludarabine in paediatric and adult patients undergoing allogeneic haematopoietic stem cell transplantation conditioning.
Nath CE, Rosser SPA, Nath KK, Chung J, Larsen S, Gibson J, Gabriel M, Shaw PJ, Keogh SJ. Nath CE, et al. Eur J Clin Pharmacol. 2024 Dec;80(12):1967-1987. doi: 10.1007/s00228-024-03751-0. Epub 2024 Sep 19. Eur J Clin Pharmacol. 2024. PMID: 39298000 Free PMC article.
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial.
Cavallaro G, Grassi A, Pavoni C, Micò MC, Busca A, Cavattoni IM, Santarone S, Borghero C, Olivieri A, Milone G, Chiusolo P, Musto P, Saccardi R, Patriarca F, Pane F, Saporiti G, Rivela P, Terruzzi E, Cerretti R, Marotta G, Carella AM, Nagler A, Russo D, Corradini P, Bernasconi P, Iori AP, Castagna L, Mordini N, Oldani E, Di Grazia C, Bacigalupo A, Rambaldi A. Cavallaro G, et al. Blood Cancer J. 2024 Aug 21;14(1):141. doi: 10.1038/s41408-024-01116-5. Blood Cancer J. 2024. PMID: 39168989 Free PMC article. Clinical Trial.
Melphalan Dose in Combination With Fludarabine Affects Gastrointestinal Toxicity and Graft-Versus-Host Disease After Allogeneic Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Albanyan O, Elmariah H, Kalos D, Kim J, Faramand R, Sallman D, Mishra A, Sweet K, Perez L, Ochoa-Bayona J, Nieder M, Komrokji R, Lancet J, Fernandez H, Nishihori T, Pidala J, Anasetti C, Bejanyan N. Albanyan O, et al. Transplant Cell Ther. 2024 Nov;30(11):1090.e1-1090.e10. doi: 10.1016/j.jtct.2024.08.007. Epub 2024 Aug 13. Transplant Cell Ther. 2024. PMID: 39147136
3,916 results